je.st
news
Novo Nordisk diabetes drug fails to help heart failure: study
2015-11-09 01:18:18| Biotech - Topix.net
ORLANDO: The Novo Nordisk diabetes drug Victoza failed to improve clinical stability or delay death in patients suffering from advanced heart failure, researchers reported at a medical meeting on Sunday. The injectable drug, known chemically as liraglutide, was tested in 300 patients with and without type 2 diabetes who had advanced heart failure and a recent hospitalization.
Tags: study
heart
drug
failure
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||